Home / Drugs / Fedratinib Hydrochloride

Fedratinib Hydrochloride

FDA Drug Profile — Inrebic

Drug Details

Generic Name
Fedratinib Hydrochloride
Brand Names
Inrebic
Application Number
NDA212327
Sponsor
Celgene Corporation
NDC Codes
2
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
FEDRATINIB HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE INREBIC ® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) ( 1 ).